Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer

Published:2024-09 Issue: Volume:201 Page:104427
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Guerini-Rocco Elena,Venetis Konstantinos,Cursano Giulia,Mane Eltjona,Frascarelli Chiara,Pepe Francesco,Negrelli Mariachiara,Olmeda Edoardo,Vacirca Davide,Ranghiero Alberto,Trapani Dario,Criscitiello Carmen,Curigliano Giuseppe,Rolfo Christian,Malapelle Umberto,Fusco Nicola^ORCID

Funder

Ministero della Salute

Fondazione Umberto Veronesi

Publisher

Elsevier BV

Reference70 articles.

1. Administration USFaD, 2020. Administration USFaD. Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices.

2. Circulating tumor DNA in breast cancer: a biomarker for patient selection;Agostinetto;Curr. Opin. Oncol.,2023

3. HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation;Ahn;J. Pathol. Transl. Med,2020

4. The role of the pathologist in the next-generation era of tumor molecular characterization;Angerilli;Diagn. (Basel),2021

5. ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients;Angus;Cancer Treat. Rev.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP